Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity

Jodee L. Johnson, Sanjeewa G. Rupasinghe, Felicia Stefani, Mary A Schuler, Elvira Demejia

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer studies have shown that inhibition of glycogen synthase kinase-3β (GSK-3β) leads to decreased cancer cell proliferation and survival by abrogating nuclear factor κB (NFκB) activity. In this investigation, various citrus compounds, including flavonoids, phenolic acids, and limonoids, were individually investigated for their inhibitory effects on GSK-3β by using a luminescence assay. Of the 22 citrus compounds tested, the flavonoids luteolin, apigenin, and quercetin had the highest inhibitory effects on GSK-3β, with 50% inhibitory values of 1.5, 1.9, and 2.0μM, respectively. Molecular dockings were then performed to determine the potential interactions of each citrus flavonoid with GSK-3β. Luteolin, apigenin, and quercetin were predicted to fit within the binding pocket of GSK-3β with low interaction energies (-76.4, -76.1, and -84.6kcalmol-1, respectively) and low complex energies (-718.1, -688.1, and -719.7kcalmol -1, respectively). Our results indicate that several citrus flavonoids inhibit GSK-3β activity and suggest that these have potential to suppress the growth of pancreatic tumors.

Original languageEnglish (US)
Pages (from-to)325-333
Number of pages9
JournalJournal of medicinal food
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Glycogen Synthase Kinase 3
Apigenin
Luteolin
Citrus
Quercetin
Flavonoids
Limonins
Luminescence
Pancreatic Neoplasms
Neoplasms
Cell Survival
Cell Proliferation
Growth

Keywords

  • GSK-3β
  • Glycogen synthase kinase-3β
  • citrus compounds
  • flavonoids
  • luminescence assay
  • molecular docking

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. / Johnson, Jodee L.; Rupasinghe, Sanjeewa G.; Stefani, Felicia; Schuler, Mary A; Demejia, Elvira.

In: Journal of medicinal food, Vol. 14, No. 4, 01.04.2011, p. 325-333.

Research output: Contribution to journalArticle

@article{4ae4880a499d46b58c353bd5179760b9,
title = "Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity",
abstract = "Pancreatic cancer studies have shown that inhibition of glycogen synthase kinase-3β (GSK-3β) leads to decreased cancer cell proliferation and survival by abrogating nuclear factor κB (NFκB) activity. In this investigation, various citrus compounds, including flavonoids, phenolic acids, and limonoids, were individually investigated for their inhibitory effects on GSK-3β by using a luminescence assay. Of the 22 citrus compounds tested, the flavonoids luteolin, apigenin, and quercetin had the highest inhibitory effects on GSK-3β, with 50{\%} inhibitory values of 1.5, 1.9, and 2.0μM, respectively. Molecular dockings were then performed to determine the potential interactions of each citrus flavonoid with GSK-3β. Luteolin, apigenin, and quercetin were predicted to fit within the binding pocket of GSK-3β with low interaction energies (-76.4, -76.1, and -84.6kcalmol-1, respectively) and low complex energies (-718.1, -688.1, and -719.7kcalmol -1, respectively). Our results indicate that several citrus flavonoids inhibit GSK-3β activity and suggest that these have potential to suppress the growth of pancreatic tumors.",
keywords = "GSK-3β, Glycogen synthase kinase-3β, citrus compounds, flavonoids, luminescence assay, molecular docking",
author = "Johnson, {Jodee L.} and Rupasinghe, {Sanjeewa G.} and Felicia Stefani and Schuler, {Mary A} and Elvira Demejia",
year = "2011",
month = "4",
day = "1",
doi = "10.1089/jmf.2010.0310",
language = "English (US)",
volume = "14",
pages = "325--333",
journal = "Journal of Medicinal Food",
issn = "1096-620X",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity

AU - Johnson, Jodee L.

AU - Rupasinghe, Sanjeewa G.

AU - Stefani, Felicia

AU - Schuler, Mary A

AU - Demejia, Elvira

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Pancreatic cancer studies have shown that inhibition of glycogen synthase kinase-3β (GSK-3β) leads to decreased cancer cell proliferation and survival by abrogating nuclear factor κB (NFκB) activity. In this investigation, various citrus compounds, including flavonoids, phenolic acids, and limonoids, were individually investigated for their inhibitory effects on GSK-3β by using a luminescence assay. Of the 22 citrus compounds tested, the flavonoids luteolin, apigenin, and quercetin had the highest inhibitory effects on GSK-3β, with 50% inhibitory values of 1.5, 1.9, and 2.0μM, respectively. Molecular dockings were then performed to determine the potential interactions of each citrus flavonoid with GSK-3β. Luteolin, apigenin, and quercetin were predicted to fit within the binding pocket of GSK-3β with low interaction energies (-76.4, -76.1, and -84.6kcalmol-1, respectively) and low complex energies (-718.1, -688.1, and -719.7kcalmol -1, respectively). Our results indicate that several citrus flavonoids inhibit GSK-3β activity and suggest that these have potential to suppress the growth of pancreatic tumors.

AB - Pancreatic cancer studies have shown that inhibition of glycogen synthase kinase-3β (GSK-3β) leads to decreased cancer cell proliferation and survival by abrogating nuclear factor κB (NFκB) activity. In this investigation, various citrus compounds, including flavonoids, phenolic acids, and limonoids, were individually investigated for their inhibitory effects on GSK-3β by using a luminescence assay. Of the 22 citrus compounds tested, the flavonoids luteolin, apigenin, and quercetin had the highest inhibitory effects on GSK-3β, with 50% inhibitory values of 1.5, 1.9, and 2.0μM, respectively. Molecular dockings were then performed to determine the potential interactions of each citrus flavonoid with GSK-3β. Luteolin, apigenin, and quercetin were predicted to fit within the binding pocket of GSK-3β with low interaction energies (-76.4, -76.1, and -84.6kcalmol-1, respectively) and low complex energies (-718.1, -688.1, and -719.7kcalmol -1, respectively). Our results indicate that several citrus flavonoids inhibit GSK-3β activity and suggest that these have potential to suppress the growth of pancreatic tumors.

KW - GSK-3β

KW - Glycogen synthase kinase-3β

KW - citrus compounds

KW - flavonoids

KW - luminescence assay

KW - molecular docking

UR - http://www.scopus.com/inward/record.url?scp=79953173629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953173629&partnerID=8YFLogxK

U2 - 10.1089/jmf.2010.0310

DO - 10.1089/jmf.2010.0310

M3 - Article

C2 - 21443429

AN - SCOPUS:79953173629

VL - 14

SP - 325

EP - 333

JO - Journal of Medicinal Food

JF - Journal of Medicinal Food

SN - 1096-620X

IS - 4

ER -